Company Profile
Petros Pharmaceuticals Stock Price, News & Analysis
- Ticker:
- PTPI
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.00 USD (+20.00%)
Close
Last updated: August 6, 2026
—
Market cap
Why the stock is moving
As of Aug 6, 2026, PTPI closed up 20.0% at $0.0030. No new same-company headline was identified in the current news window.
Company overview
Business overview
Petros Pharmaceuticals is a specialty pharmaceutical company focused on men’s health and self-care products, including sexual-health-related therapies. Its business is centered on consumer-accessible specialty medicines rather than classic biotech discovery.
Geographic Base and Sector Classification
Petros is headquartered in the United States and listed on NASDAQ. It sits in specialty pharma and men’s health.
Business Model Characteristics
The company depends on commercial execution, regulatory pathways, and the ability to expand access to a narrow product set. Investors usually watch product adoption, label strategy, and cash management.
Position Within the Biotechnology Landscape
Petros occupies a niche men’s-health specialty-pharma position. It is less about clinical-stage binary risk and more about commercial access and brand execution.
Future catalysts
Petros’s catalysts are men’s-health and sexual-health commercialization, plus any strategic update that clarifies the company’s future. The market will care about whether the product base can stabilize.
Recent news
- 01
Petros Pharmaceuticals Responds to Fraudulent Press Release
Source: Petros Pharmaceuticals
- 02
Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew Pinsky
Source: Petros Pharmaceuticals
- 03
Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update
Source: Petros Pharmaceuticals
- 04
- 05
Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022
Source: Petros Pharmaceuticals
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Petros Pharmaceuticals (PTPI)?
Petros Pharmaceuticals (PTPI) most recently closed at 0.00 USD, a +20.00% move versus the previous session.
What does Petros Pharmaceuticals do?
Petros Pharmaceuticals is a specialty pharmaceutical company focused on men’s health and self-care products, including sexual-health-related therapies. Its business is centered on consumer-accessible specialty medicines rather than classic biotech discovery.
On which exchange is PTPI stock listed?
Petros Pharmaceuticals (PTPI) is associated with NASDAQ, United States, Biopharma.
What is Petros?
Petros’s catalysts are men’s-health and sexual-health commercialization, plus any strategic update that clarifies the company’s future.
Which conditions is Petros Pharmaceuticals targeting with Petros?
Petros’s catalysts are men’s-health and sexual-health commercialization, plus any strategic update that clarifies the company’s future.
How does Petros Pharmaceuticals describe recent progress with Petros?
Petros’s catalysts are men’s-health and sexual-health commercialization, plus any strategic update that clarifies the company’s future.
What is Pharmaceuticals?
Petros Pharmaceuticals is a specialty pharmaceutical company focused on men’s health and self-care products, including sexual-health-related therapies.
What should investors watch for with Pharmaceuticals?
Petros’s catalysts are men’s-health and sexual-health commercialization, plus any strategic update that clarifies the company’s future. The market will care about whether the product base can stabilize.